Login to Your Account

Market Report Q213

Biotechs Burning Rubber as Fundraising Still in Overdrive

By Peter Winter

Monday, July 8, 2013

Global biotech companies continued their torrid fundraising pace generating almost $6 billion in the second quarter of 2013, a 20 percent uptick on the respectable $5 billion raised in the first quarter of this year. In the period public companies led the way, taking advantage of their ever improving share values to conduct public financings.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription